Live Breaking News & Updates on Selecta Biosciences Imm

Stay updated with breaking news from Selecta biosciences imm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials

Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid ....

United States , University Of Texas Southwestern Medical Center , Roy Fleischmann , Selecta Biosciences Imm , Herbert Sb Baraf , Biovitrum Sobi , European Congress , George Washington University , Metroplex Clinical Research Center , Drug Administration , Selecta Biosciences , Swedish Orphan Biovitrum , Texas Southwestern Medical Center , Immune Tolerance , Oint Inflammation , Body Mass Index Bmi , Clinical Research , Clinical Trials , Linical Studies , Quality Of Life , Ealth Related Quality Of Life , Biologic Therapy , Healthcare And Medical ,